Objective: To review and critically appraise the existing evidence on integration of STI services into HIV care and treatment services for women living with HIV.
• Examining the evidence for integrating two related health services -sexually transmitted infection services and HIV services -for women living with HIV who have specific needs • Systematic search, screening and data abstraction process to evaluate the global literature on integration of STI services into HIV care and treatment services • While few studies were identified that met the inclusion criteria, the existing data indicate that integration can be feasible and can have positive outcomes, though differences were seen across settings and populations. 
Key Messages
• STI assessment and treatment is key to ensuring the sexual and reproductive health of women living with HIV.
• Our systematic review of the literature identified just three comparative studies examining the integration of STI services into HIV care and treatment services.
• Two United Kingdom studies found integration improved STI service quality and uptake;
in Swaziland, integrated sites reported higher Pap smear coverage but lower client satisfaction.
• STI/HIV integration is feasible and possibly beneficial, although local preferences and health system differences suggest a single approach will not work equally everywhere. 
BACKGROUND
The 2030 Agenda for Sustainable Development defines a set of ambitious global health goals and targets, including the need to ensure healthy lives and promote well-being for all at all ages (Goal 3). [1] To ensure the health sector implementation of this Agenda, the World Health Organization (WHO) has developed global health sector strategies on HIV, viral hepatitis, and sexually transmitted infections (STIs) which were adopted by the United Nations Member States in May 2016. [2, 3 ,4] Among the common priorities across the three strategies is the imperative to strengthen health systems to support integrated service delivery by identifying the best methods and approaches for delivering a continuum of high-impact, tailored health interventions and services to different populations and in different locations in order to achieve equity and ensure quality.
It is estimated that annually there are 357 million new cases of four curable STIs among people aged 15-49 years: Chlamydia trachomatis (131 million), Neisseria gonorrhoeae (78 million), syphilis (6 million), and Trichomonas vaginalis (142 million). [4] The prevalence of some viral STIs is similarly high, with an estimated 417 million people infected with herpes simplex type 2, and approximately 291 million women harbouring the human papillomavirus. [4] Sexually transmitted co-infections increase HIV transmissibility through local inflammatory processes in addition to compromising quality of life, as well as sexual and reproductive health and newborn and child health. [5] For women living with HIV, a holistic and comprehensive approach to sexual and reproductive health and rights includes enhancing services to identify and treat STIs. Women living with HIV have high rates of STI co-infection; a recent systematic review of 37 studies found a mean STI prevalence among women of 15.8% (standard deviation: 9.9). [6] Screening and treatment for STIs have been recommended as a part of the package of care for people living with HIV by the WHO; [7, 8] they are also part of PEPFAR's minimum package of prevention services for people living with HIV. [9] While many national HIV treatment guidelines (including those in the United Kingdom, the United States, and South Africa) recommend that STI screening occur within routine HIV care visits, published service statistics indicate that coverage rates for the recommended sexual history and STI screening are often very low. For example, among a nationally representative sample of women in HIV treatment in the U.S., the coverage of testing from 2008-2010 among sexually active women was only 49% for syphilis, 30% for chlamydia, and 28% for gonorrhoea. [10] A key approach to increasing coverage of STI services for people living with HIV is integration of these services within HIV care and treatment settings. As part of an effort to inform updated WHO guidelines on sexual and reproductive health and rights for women living with HIV, we sought to systematically review the evidence for the integration of STI services into HIV care and treatment services for women living with HIV. Our goal was to identify the models of integrating STI services into HIV care and treatment services for people living with HIV that have been evaluated and their associated outcomes. 
METHODS

F
Definitions
There is no agreed-upon definition of service integration, and no clear distinction between integrated and non-integrated services. [11] The WHO has defined integration as the "management and delivery of health services so that clients receive a continuum of preventive and curative services, according to their needs over time and across different levels of the health system." [12] For the purposes of this review, we used this definition of integration and focus on the service delivery level, rather than at the policy or other levels.
We considered STI services to include sexual history screening, information and advice on avoiding re/infection, access to partner notification services and disclosure support, when appropriate, and testing, treatment, and syndromic management of all STIs other than HIV, since we were looking at the integration of STI services with HIV services. Reports of the integration of cervical cytology (Pap smears) into HIV care and treatment settings absent of other STI services were not included in the review as these are generally considered reproductive health services.
PICO question and inclusion criteria
The review addressed the following PICO question: Should STI services be integrated into HIV care and treatment services for women living with HIV? No restrictions were placed based on location of the intervention. No language restrictions were used on the search. We followed PRISMA guidelines for reporting systematic review results. [13] A full review protocol was developed and is available from the corresponding author upon request. For articles published through December 31, 2007, we screened the results from a systematic review of sexual and reproductive health for people living with HIV published in 2011. [14] We then searched the following electronic databases for articles published from January 1, 2008, through the search date of August 12, 2016: PubMed, CINAHL (Cumulative Index to Nursing and Allied Health Literature), and EMBASE. Secondary reference searching was conducted on all studies included in the review, and two other related reviews. [15, 16] 
Search strategy
Search terms
The following terms used to search PubMed and were adapted for the controlled vocabulary of the other computer databases: ("sexually transmitted infection" [tiab] 
Screening abstracts
Titles, abstracts, citation information, and descriptor terms of citations identified through the search strategy underwent an initial screening by a member of the study staff. Remaining abstracts then were screened in duplicate by two reviewers working independently with adjudication of differences by a senior member of the study team. Full text articles were obtained of all selected abstracts, and two independent reviewers assessed all full-text articles for eligibility to determine final study selection. Online database searching yielded 249 hits, of which there were 170 unique citations after removing duplicates (Figure 1 ). After initial screening of titles and abstracts, 98 citations remained for double-screening. These were double-screened and 40 were pulled for full-text review. Of these, one study (reported in two articles) was considered eligible for inclusion. In addition, two studies were included from the prior systematic review covering articles though 2007. [14] Therefore, a total of three studies reported in four articles met the criteria for inclusion in the review. Table 1 presents descriptions of the study settings, methods, and outcomes. Table  2 presents an assessment of study rigor. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Study design:
Serial crosssectional (comparing 100 consecutive patients in a 3-day period before and after the intervention was implemented).
Unit of analysis: Individual
Selection of participants:
Non-random Of the three included articles, two offered comprehensive care to people living with HIV in the United Kingdom, although types of care differed. The first study reported on an integrated sexual health care clinic for HIV-positive women that included screening for STIs, contraception, preconception counselling, and cervical cytology. [19] This study reported on quality of services offered, which all improved at 12-month follow-up after the integration began. Uptake of cervical cytology improved from 63% of patients to 83%; sexual history recorded increased from 77% to 97%; and STI screen offered increased from 70% to 83%. The second study reported on a sexual health clinic for HIV-positive women designed to improve uptake of STI screening, as well as offer hepatitis B, vaccination, and cervical smear testing. [20] The primary outcome was quality of services offered, and all related outcomes improved after the clinic opened. Documentation that an annual health discussion had taken place between provider and patient improved from 37% before the intervention to 70% after (p<0.0001); having an annual STI screen improved from 26% of participants to 46% (p=0.003); and screening for hepatitis B improved negligibly, from 93% to 94%. [20] The final study, reported in two articles, [21, 22] was a comparative case study examining the relationship between integration and the use and demand for SRH services (including STI services), and client satisfaction across different models of care in Swaziland: two clinics integrated with SRH services and two stand-alone HIV clinics (which did not provide STI services). An exit survey (n = 602) measured SRH services and satisfaction across model using logistic regression; a complementary qualitative assessment was also conducted. Women attending the fully integrated site were more likely to have had a Pap smear since testing positive than women attending the less integrated service models (35% v. 11%, 14% and 10%, p<0.001). However, clients attending the fully integrated site were not more likely to report having sexual 
DISCUSSION
Despite significant STI burden among women living with HIV and increased attention to integration of services, there is limited evidence on the impact of integrating STI services into HIV care and treatment centres. We identified just three studies from two countries that provided comparative data on our outcomes of interest. In two studies from the UK, quality and uptake of STI services seemed to improve following integration. However, in Swaziland, people living with HIV generally reported higher satisfaction at a stand-alone HIV clinic than with integrated services, and clients attending the integrated sites were no more likely than those at nonintegrated sites to have had a sexual health screening. A diverse range of factors related to implementation of different care models challenged the notion that integrated services are always superior or desired; instead, the authors concluded that different models may work for different types of clients and the diversity of client needs and preferences, along with health system factors, should be considered when developing integrated services. [21] Our review was limited by the small number of articles identified that met our inclusion criteria, limiting the evidence base from which we can draw conclusions. Further, the study designs were cross-sectional or serial cross-sectional with modest sample sizes, limiting the inferences that can be drawn. The number and type of outcomes were also limited. Because many national HIV guidelines indicate that STI screening should occur within routine HIV clinical care visits, evaluations may have focused on routine program monitoring and quality assurance rather than comparing models of service delivery.
[23] For example, in Scotland, an audit of facilities serving people living with HIV found that less than half of sites met the guidelines for offering STI screening and recording sexual history among at least 80% of patients within four weeks of diagnosis, with wide variability in performance across sites.
[24] In Thailand, quality improvement initiative among 12 HIV care sites documented a significant increase in coverage of STI services, including an increase from 0% to 94% in median coverage for syphilis serology, and an increase from 0% to 67% in cervical cancer screening.
[23] As part of the quality improvement initiative, a checklist of services that included STI screening was developed and a new standard operating procedure was initiated offering routine gynaecologic examination and Pap smears to all HIV-infected women. In settings where STI services are available in HIV clinics, quality improvement and performance monitoring frameworks may be valuable approaches to improve outcomes, while also documenting service delivery strategies and coverage.
Further documentation of diverse service models using comparative designs would help to inform program implementation. However, there is evidence from community-based clinic settings that STI screening can be increased at relatively low cost through strategies such as the strategic placement of specimen collection materials or automatic specimen collection as part of a routine visit, the use of electronic health records, and the use of patient reminders (via text, telephone, and postcards). [25] Such strategies would likely work in HIV care and treatment settings as well.
Several SRH service integration initiatives with HIV care and treatment hold promise for better provision of STI services. Many PEPFAR-supported sites have rolled out elements of positive health, dignity, and prevention which includes STI services for people living with HIV, so in future years more evidence of STI/HIV integration may be forthcoming, particularly from high-HIV burden settings. [26] The integration of cervical cancer screening in HIV treatment sites in resource-limited settings in recent years has demonstrated feasibility and acceptability. [27, 28] The creation of private spaces for pelvic examinations provides an opportunity for STI screening among HIV-infected women. In the United States, women living with HIV had 1.9 times the odds of having a Pap smear in the last year if gynaecology services were co-located with their primary HIV care [28] and a recent study found that women with HIV were significantly more likely to have been screened for gonorrhoea and chlamydia if they had also had a Pap smear in the past year. [27] As country initiatives in the elimination of mother-to-child transmission (EMTCT) and Option B+ (immediate initiation of pregnant women on antiretroviral therapy [ART]) are expanded, more women living with HIV are being diagnosed in antenatal and postnatal care settings where HIV care and treatment is also being provided. With the WHO strategy for dual elimination of HIV and syphilis, antenatal and postnatal care settings may become key sites for the integration of STI services with HIV care and treatment. Further, antenatal care settings and other maternal, neonatal, and child health (MNCH) services may require integration with STI services regardless of whether HIV care and treatment services are also provided, as the assumption that SRH is already an automatically linked set of services is often not accurate.
In line with a people-centred approach, grounded in principles of human rights, gender equality and health equity, the WHO global strategies on HIV, STIs, and viral hepatitis aim to facilitate people's access to information, improve access to treatment and comprehensive long-term care when needed, and challenge pervasive stigmatization and discrimination. The provision of STI services within HIV treatment settings is one way to reach many national STI screening guidelines for women living with HIV. Despite the limited evidence base, the studies identified in this review did document the feasibility of integrating STI services into HIV care and treatment settings and the potential for positive outcomes of such integration. Programs should be encouraged by this evidence to critically consider whether integration might prove beneficial in their particular settings to improve access to comprehensive, holistic services that address the sexual and reproductive health needs of women living with HIV.
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Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
6 Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
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Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
Risk of bias in individual studies 12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis. 
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Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
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Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).
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Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
10-11
Synthesis of results 21 Present the main results of the review. If meta-analyses are done, include for each, confidence intervals and measures of consistency.
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15).
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Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
11-12
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias). Design: Systematic review.
Data Sources: Four electronic databases were searched through February 16, 2017, using keywords for HIV, STIs, and integration. Reference lists of included articles and other reviews were also screened.
Review methods:
We included studies that compared women living with HIV who received STI services integrated into HIV care and treatment services with those who received HIV care and treatment services without integrated STI services or standard of care.
Results:
Of 170 articles identified, three studies reported in four articles were included. Two studies evaluated comprehensive care for people living with HIV in the United Kingdom; in both cases, quality and uptake of STI services seemed to improve following integration. The third study conducted a comparative case study across different models of care in Swaziland: two clinics integrated with sexual and reproductive health services (including STI services), and two stand-alone HIV clinics (without STI services). Coverage for Pap smears among women living with HIV was higher at the fully integrated site, but there was no significant difference in the prevalence of sexual health screening or advice on sexual health. Reported client satisfaction was generally higher at the stand-alone HIV clinic, and a diverse range of factors related to implementation of different care models challenged the notion that integrated services are always superior or desired.
Conclusion:
While there is a limited evidence base for integrating STI services into HIV care and treatment services, existing studies indicate that integration is feasible and has the potential for positive outcomes. However, diverse population needs and health system factors must be considered when designing models of care to provide STI services to women living with HIV.
Strengths and limitations of this study
• Examining the evidence for integrating two related health services -sexually transmitted infection services and HIV services -for women living with HIV who have specific needs • Systematic search, screening and data abstraction process to evaluate the global literature on integration of STI services into HIV care and treatment services • While few studies were identified that met the inclusion criteria, the existing data indicate that integration can be feasible and can have positive outcomes, though differences were seen across settings and populations. [4] [5] There is substantial evidence that STIs also increase HIV transmissibility as well as HIV acquisition risk, by as much as 2 to 3 times in some populations. [4, 6] For women living with HIV, a holistic and comprehensive approach to sexual and reproductive health and rights includes enhancing services to identify and treat STIs. Women living with HIV have high rates of STI co-infection; a recent systematic review of 37 studies found a mean STI prevalence among these women of 15.8% (standard deviation: 9.9). [7] Screening and treatment for STIs have been recommended as a part of the package of care for people living with HIV by the WHO; [8] [9] they are also part of PEPFAR's minimum package of prevention services for people living with HIV. [10] While many national HIV treatment guidelines (including those in the United Kingdom, the United States, and South Africa) recommend that STI screening occur within routine HIV care visits, published service statistics indicate that coverage rates for the recommended sexual history and STI screening are often very low. [11] [12] [13] [14] For example, among a nationally representative sample of women in HIV treatment in the U.S., the coverage of testing from 2008-2010 among sexually active women was only 49% for syphilis, 30% for chlamydia, and 28% for gonorrhoea. [15] A key approach to increasing coverage of STI services for people living with HIV is integration of these services within HIV care and treatment settings. As part of an effort to inform updated WHO guidelines on sexual and reproductive health and rights for women living with HIV, we sought to systematically review the evidence for the integration of STI services into HIV care and treatment services for women living with HIV. Our goal was to identify the models of integrating STI services into HIV care and treatment services for people living with HIV that have been evaluated and their associated outcomes. 
METHODS
Definitions
There is no agreed-upon definition of service integration, and no clear distinction between integrated and non-integrated services. [16] The WHO has defined integration as the "management and delivery of health services so that clients receive a continuum of preventive and curative services, according to their needs over time and across different levels of the health system." [17] For the purposes of this review, we used this definition of integration and focus on the service delivery level, rather than at the policy or other levels.
We considered STI services to include sexual history screening, information and advice on avoiding re/infection, access to partner notification services and disclosure support, when appropriate, and testing, treatment, and/or syndromic management of any STIs other than HIV, since we were looking at the integration of STI services with HIV services. The integration of cervical cancer screening by Pap tests (or smears) into HIV care and treatment settings absent of one or more of the aforementioned STI services was not considered sufficient to constitute integrated STI services. No language restrictions were used on the search. We followed PRISMA guidelines for reporting systematic review results. [19] A full review protocol was developed and is available from the corresponding author upon request.
Research question and inclusion criteria
Search strategy
We searched the following electronic databases for articles published anytime through the search date of February 16, 2017: PubMed, CINAHL (Cumulative Index to Nursing and Allied Health Literature), and EMBASE. Search terms were developed for STIs, HIV, and integration and combined; the full search strategy for each database is available in Supplementary File 1. Secondary reference searching was conducted on all studies included in the review, and three other related reviews. [20] [21] [22] Screening abstracts Titles, abstracts, citation information, and descriptor terms of citations identified through the search strategy underwent an initial screening by a member of the study staff. Remaining abstracts then were screened in duplicate by two reviewers working independently with adjudication of differences by a senior member of the study team. Full text articles were obtained of all selected abstracts, and two independent reviewers assessed all full-text articles for eligibility to determine final study selection.
Data extraction and management
For each study, the following information was extracted: study citation, location, setting, target group, intervention description, study design, unit of analysis, selection of participants, sample size, age, gender, and reported numerical outcomes and results.
Assessment of study rigour was conducted based on a nine-item tool, including items for: (1) Study design includes pre/post intervention data, (2) Study design includes control or comparison group, (3) Study design includes cohort, (4) Comparison groups equivalent at baseline on socio-demographics, (5) Comparison groups equivalent at baseline on outcome measures, (6) Random assignment (group or individual) to the intervention, (7) Participants randomly selected for assessment, (8) Control for potential confounders, and (9) Follow-up rate >=75%. This tool was based on the eight-item rigour assessment for systematic reviews of HIV behavioural interventions with a range of study designs (beyond randomized trials) developed by the Evidence Project. [23] [24] Data analysis Data were analysed according to coding categories and outcomes. Meta-analysis was not conducted due to the small number of included studies.
RESULTS
Online database searching yielded 406 hits, of which there were 235 unique citations after removing duplicates (Figure 1 ). After initial screening of titles and abstracts, 104 citations remained for double-screening. These were double-screened and 40 were pulled for full-text review. Of these, one study (reported in two articles) was considered eligible for inclusion. In addition, two studies were included from the prior systematic review covering articles though 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 [20] Therefore, a total of three studies reported in four articles met the criteria for inclusion in the review. Table 1 presents descriptions of the study settings, methods, and outcomes. Table  2 presents an assessment of study rigour. 
Study design:
Cross-sectional
Unit of analysis: Individual
Selection of participants:
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Study design:
Serial crosssectional (comparing 100 consecutive patients in a 3-day period before and after the intervention was implemented). Of the three included articles, two evaluated the creation of new sexual health clinics within existing services for people living with HIV in the United Kingdom. The first study reported on an integrated sexual health care clinic for HIV-positive women that included screening for STIs, contraception, preconception counselling, and cervical cytology. [25] This study reported on quality of services offered, which all improved at 12-month follow-up after the integration began. Uptake of cervical cytology improved from 63% of patients to 83%; sexual history recorded increased from 77% to 97%; and STI screen offered increased from 70% to 83%. The second study reported on a sexual health clinic for HIV-positive women designed to improve uptake of STI screening, as well as offer hepatitis B, vaccination, and cervical smear testing. [26] The primary outcome was quality of services offered, and all related outcomes improved after the clinic opened. Documentation that an annual health discussion had taken place between provider and patient improved from 37% before the intervention to 70% after (p<0. The final study, reported in two articles, [27] [28] was a comparative case study examining the relationship between integration and the use and demand for sexual and reproductive health services (including STI services), and client satisfaction across different models of care in Swaziland: two clinics integrated with sexual and reproductive health services and two standalone HIV clinics (which did not provide STI services). In addition to employing a different study design than the previous two studies (a comparison across clinic models rather than a comparison before and after initiation of new services), this study had slightly higher overall rigour assessment as it randomly selected clients for assessment and adjusted for confounders ( Table 2 ). An exit survey (n = 602) measured service use and satisfaction across models using logistic regression; a complementary qualitative assessment was also conducted. Women attending the fully integrated site were more likely to have had a Pap smear since testing positive than women attending the less integrated service models (35% v. 11%, 14% and 10%, p<0.001). However, clients attending the fully integrated site were not more likely to report having sexual health screening (45% v. 57%, 76%, and 42% from most to least integrated, respectively) or advice on sexual health (16% v. 12%, 16%, and 11%, from most to least integrated 
Unit of analysis: Individual
Selection
DISCUSSION
Despite significant STI burden among women living with HIV and increased attention to integration of services, there is only modest evidence on the impact of integrating STI services into HIV care and treatment centres. We identified just three studies from two countries that provided comparative data on our outcomes of interest. In two studies from the United Kingdom, quality and uptake of STI services seemed to improve following introduction of new sexual health clinics into existing HIV services. However, in Swaziland, people living with HIV generally reported higher satisfaction at a stand-alone HIV clinic than at integrated service sites, and clients attending the integrated sites were no more likely than those at non-integrated sites to have had a sexual health screening. In this latter study, a diverse range of factors related to implementation of different care models challenged the notion that integrated services are always superior or desired; instead, the authors concluded that different models may work for different types of clients and the diversity of client needs and preferences, along with health system factors, should be considered when developing integrated services. [27] Our review identified only a small number of articles that met the inclusion criteria, limiting the evidence base from which we can draw conclusions. Further, the study designs were crosssectional or serial cross-sectional with modest sample sizes, limiting the inferences that can be drawn. The number and type of outcomes were also limited. The evidence gap does not necessarily reflect the lack of integrated STI and HIV services, but rather the paucity of comparative evaluations of such integration. Notably, because many national HIV guidelines indicate that STI screening should occur within routine HIV clinical care visits, evaluations may have focused on routine programme monitoring and quality assurance rather than comparing models of service delivery. [29] For example, in Scotland, an audit of facilities serving people living with HIV found that less than half of sites met the guidelines for offering STI screening and recording sexual history among at least 80% of patients within four weeks of diagnosis, with wide variability in performance across sites. [30] In Thailand, quality improvement initiative among 12 HIV care sites documented a significant increase in coverage of STI services, including an increase from 0% to 94% in median coverage for syphilis serology, and an increase from 0% to 67% in cervical cancer screening. [29] As part of the quality improvement initiative, a checklist of services that included STI screening was developed and a new standard operating procedure was initiated offering routine gynaecologic examination and Pap smears to all HIVinfected women. In settings where STI services are available in HIV clinics, quality improvement and performance monitoring frameworks may be valuable approaches to improve outcomes, while also documenting service delivery strategies and coverage.
Further documentation of diverse service models using comparative designs would help to inform programme implementation. However, there is evidence from community-based clinic settings that STI screening can be increased at relatively low cost through strategies such as the strategic placement of specimen collection materials or automatic specimen collection as part of a routine visit, the use of electronic health records, and the use of patient reminders (via text, telephone, and postcards). [31] Such strategies would likely work in HIV care and treatment settings as well.
Several service integration initiatives hold promise for better provision of STI services within HIV care and treatment settings. Many PEPFAR-supported sites have rolled out elements of positive health, dignity, and prevention which includes STI services for people living with HIV, so in future years more evidence of STI/HIV integration may be forthcoming, particularly from high-HIV burden settings. [32] The integration of cervical cancer screening in HIV treatment sites in resource-limited settings in recent years has demonstrated feasibility and acceptability. [33] [34] The creation of private spaces for pelvic examinations provides an opportunity for STI screening among HIV-infected women. In the United States, women living with HIV had 1.9 times the odds of having a Pap smear in the last year if gynaecology services were co-located with their primary HIV care [34] and a recent study found that women with HIV were significantly more likely to have been screened for gonorrhoea and chlamydia if they had also had a Pap smear in the past year. [33] As country initiatives in the elimination of mother-to-child transmission (EMTCT) and In line with a people-centred approach, grounded in principles of human rights, gender equality and health equity, the WHO global strategies on HIV, STIs, and viral hepatitis aim to facilitate people's access to information, improve access to treatment and comprehensive long-term care when needed, and challenge pervasive stigmatization and discrimination. The provision of STI services within HIV treatment settings is one way to reach many national STI screening guidelines for women living with HIV. Despite the limited evidence base, the studies identified in this review did document the feasibility of integrating STI services into HIV care and treatment settings and the potential for positive outcomes of such integration. Programmes should be encouraged by this evidence to critically consider whether integration might prove beneficial in their particular settings to improve access to comprehensive, holistic services that address the sexual and reproductive health needs of women living with HIV. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
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